From: Modelling the cost-effectiveness of pay-for-performance in primary care in the UK
Drug classa | DDD/PU/mob | Annual pricec |
---|---|---|
Lipid regulating drugs | 1.92 | 61.57 |
Renin angiotensin | 0.84 | 37.29 |
Thiazides/diuretics | 0.24 | 5.66 |
Oral antidiabetic | 0.14 | 42.79 |
Antiplatelet | 0.33 | 14.77 |